Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Esophageal Neoplasms × Electroporation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 13 Prostatic Neoplasms 8 Carcinoma, Hepatocellular 7 Liver Neoplasms 5 Neoplasm Metastasis 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Unresectable Pancreatic Cancer 2 Stomach Neoplasms 2 Squamous Intraepithelial Lesions 2 Neoplasms 2 Melanoma 2 Lymphatic Metastasis 2 Locally Advanced Pancreatic Cancer 2 Cholangiocarcinoma 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Adenocarcinoma Resectable 1 Liver, Cancer of, Non-Resectable 1 Liver Metastasis Colon Cancer 1

Interventions

Cisplatin 146 Fluorouracil 123 Paclitaxel 114 Radiotherapy 105 Oxaliplatin 80 Docetaxel 65 Carboplatin 60 Irinotecan 55 pembrolizumab 53 Leucovorin 53 Capecitabine 52 Radiation 42 Surgical Procedures, Operative 31 Esophagectomy 27 Drug Therapy 27 Cetuximab 24 Nivolumab 21 Bevacizumab 21 Trastuzumab 19 Neoadjuvant Therapy 19 camrelizumab 17 S 1 (combination) 17 Chemoradiotherapy 16 Albumin-Bound Paclitaxel 16 Magnetic Resonance Spectroscopy 14 tislelizumab 13 Epirubicin 13 Cyclophosphamide 13 Taxes 12 Radiotherapy, Intensity-Modulated 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02430701 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡